What does the EMA Binding Test include?
This test measures the binding of EMA dye to red blood cells to detect membrane protein deficiencies indicative of hereditary spherocytosis.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated flow cytometry protocols with EMA dye under strict quality control to accurately identify affected red blood cells.
Who should take this test?
Patients with suspected hereditary spherocytosis, unexplained anemia, jaundice, or a family history of the condition may be advised to take this test.
What sample type is required?
An EDTA-anticoagulated blood sample is required for precise and reproducible measurement.
Why is the EMA Binding Test important?
It provides a sensitive and specific method to confirm hereditary spherocytosis and helps guide clinical management and treatment decisions.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows strict quality control, validated flow cytometry protocols, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No fasting or special preparation is required; patients should follow any instructions provided by their physician regarding sample collection.
How soon are results available?
Turnaround time may vary, but Metropolis Healthcare typically provides timely reports to support diagnosis and clinical decision-making.